National Advocacy Archive
Find testimony, comments, letters, and legal briefs the American Lung Association has submitted to Congress and federal agencies in support of our public policy agenda.
Jul 16, 2018
Partners Letter to Michigan Department of Health and Human Services re Section 1115 Waiver
Jul 16, 2018
Partners' Comments to FDA re Nicotine Standard ANPRM
Jul 16, 2018
Patient and Provider Group Letter to CMS Administrator re Risk Adjustment
Jul 16, 2018
Testimony from Kevin Stewart at the DE hearing on the Section 126 petitions to EPA on transported ozone
Jul 13, 2018
Letter to Defense Appropriators re Lung Cancer Research Funding
Jul 10, 2018
Testimony from Janice Nolen on EPA's proposed NAAQS for SO2
Jul 06, 2018
Partner Comments to HHS and TRE re Maine Section 1332 Waiver Request
Jun 26, 2018
American Lung Association Comments to HHS re: Medicare Program: Hospital Inpatient Psychiatric Prospective Payment System and Quality Reporting Updates for Fiscal Year Beginning October 1, 2018 (FY 2019) [CMS 0 1690 - P]
Jun 25, 2018
American Lung Association Comments to HHS re: Medicare Program Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and Long-Term Care Hospital Prospective Payment System and other Value Based Proposals (CMS – 1694-P)
Jun 22, 2018
